title: Adenosine triphosphate affects interleukin -1beta release by T98G glioblastoma cells through a purinoceptor-independent mechanism.
abstract: T98G glioblastoma cells were previously shown to significantly increase interleukin-1beta (IL-1beta) mRNA levels in response to IL-1beta stimulation. This work demonstrates that in such conditions T98G, despite possessing biologically active interleukin converting enzyme, do not release detectable amounts of IL-1beta, even in the presence of 20 mM adenosine triphosphate (ATP). IL-1beta secretion is observed only following concomitant stimulation with 1000 units/ml of IL-1beta and 20 mM ATP. ATP induces a dose-dependent depolarization of T98G plasma membrane, whereas it does not affect Ca(2+) concentration or cell membrane permeability. Our data, together with the observation that the depolarizing effects of ATP are retained after preincubation with 100 microM suramin, an antagonist of P2-purinoceptors, suggest that ATP plays a role in IL-1beta secretion by T98G but its effects do not occur through P2-purinoceptors.
authors.affiliation: A.C.R.A.F. - Angelini Ricerche, Piazzale della Stazione snc, 00040 Santa Palomba-Pomezia, Rome, Italy.
authors.forename: A C
authors.initials: AC
authors.lastname: de Joannon
authors.forename: F
authors.initials: F
authors.lastname: Mancini
authors.forename: C
authors.initials: C
authors.lastname: Landolfi
authors.forename: L
authors.initials: L
authors.lastname: Soldo
authors.forename: A
authors.initials: A
authors.lastname: Leta
authors.forename: A
authors.initials: A
authors.lastname: Ruggieri
authors.forename: G
authors.initials: G
authors.lastname: Mangano
authors.forename: L
authors.initials: L
authors.lastname: Polenzani
authors.forename: M
authors.initials: M
authors.lastname: Pinza
authors.forename: C
authors.initials: C
authors.lastname: Milanese
mesh_terms: D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005909:Glioblastoma / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism*; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D058919:Purinergic P2 Receptor Antagonists; D018048:Receptors, Purinergic P2 / Q000502:physiology; D013498:Suramin / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D007375:Interleukin-1; D058919:Purinergic P2 Receptor Antagonists; D018048:Receptors, Purinergic P2; D013498:Suramin; D000255:Adenosine Triphosphate